Edition:
United Kingdom

Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

1.86USD
5:40pm BST
Change (% chg)

$-0.02 (-1.06%)
Prev Close
$1.88
Open
$1.90
Day's High
$1.99
Day's Low
$1.75
Volume
6,294
Avg. Vol
29,755
52-wk High
$17.23
52-wk Low
$1.71

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 -0.006
Sep '17 0.00 -0.009
Jun '17 0.00 -0.000
Mar '17 0.00 -0.011
FY 2016 Dec '16 0.00 -0.007
Sep '16 0.00 -0.000
Jun '16 0.00 -0.005
Mar '16 0.00 -0.003
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 1 0.00 0.00 0.00 0.00
Quarter Ending Sep-18 1 10.00 10.00 10.00 0.00
Year Ending Dec-18 3 3.33 10.00 0.00 0.00
Year Ending Dec-19 3 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-18 2 -0.42 -0.30 -0.54 --
Quarter Ending Sep-18 2 -0.47 -0.26 -0.68 --
Year Ending Dec-18 2 -1.80 -0.90 -2.71 -3.81
Year Ending Dec-19 2 -2.12 -0.83 -3.42 -3.87
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.02 32.74
P/E High - Last 5 Yrs. -- 293.16 45.72
P/E Low - Last 5 Yrs. -- 91.58 24.22
Beta -8.40 0.90 0.88
Price to Sales (TTM) -- 110.88 5.71
Price to Book (MRQ) 3.11 13.58 5.37
Price to Tangible Book (MRQ) 3.12 14.04 6.95
Price to Cash Flow (TTM) -- 71.40 23.32
% Owned Institutions 26.54 12.75 2.17

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.71 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 399.06 9.21
Sales (TTM) vs TTM 1 Yr. Ago -- 78.82 5.69
Sales - 5 Yr. Growth Rate -- 32.16 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 95.07 25.00 19.36
EPS (TTM) vs TTM 1 Yr. Ago 71.70 -- --
EPS - 5 Yr. Growth Rate -- 38.99 10.76
Capital Spending - 5 Yr. Growth Rate -- 40.29 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.80 2.19
Current Ratio (MRQ) 3.48 5.30 2.98
LT Debt to Equity (MRQ) 0.00 22.96 12.18
Total Debt to Equity (MRQ) 0.00 24.62 16.45
Interest Coverage (TTM) -- -99.34 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.02 54.44
Gross Margin - 5 Yr. Avg. -- 51.13 52.20
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -574.72 10.96
Operating Margin (TTM) -- -718.49 4.73
Operating Margin - 5 Yr. Avg. -- -596.03 6.40
Pre-Tax Margin (TTM) -- -692.96 5.57
Pre-Tax Margin - 5 Yr. Avg. -- -599.39 6.81
Net Profit Margin (TTM) -- -694.19 1.87
Net Profit Margin - 5 Yr. Avg. -- -602.24 3.09
Effective Tax Rate (TTM) -- 22.62 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.21 23.96

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 22,625,667 846,829,796
Net Income/Employee (TTM) -1,440,585 2,971,219 99,616,056
Receivable Turnover (TTM) -- 20.16 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.00 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -48.19 -1.11 10.95
Return on Assets - 5 Yr. Avg. -69.68 -0.57 12.31
Return on Investment (TTM) -68.01 1.58 14.38
Return on Investment - 5 Yr. Avg. -103.47 2.21 16.10
Return on Equity (TTM) -68.13 2.41 16.07
Return on Equity - 5 Yr. Avg. -105.91 3.09 17.39
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 71.04 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akari Therapeutics PLC

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 24.57%
# of Holders: 20
Total Shares Held: 3,748,803
3 Mo. Net Change: -400
# New Positions: 0
# Closed Positions: 1
# Increased Positions: 0
# Reduced Positions: 1
# Net Buyers: -1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.